Lisheng Pharmaceutical: Net profit in 2021 is expected to increase by 1177%-1525% year-on-year _ Securities Times Network
Home > News > e company
Lisheng Pharmaceutical: Net profit in 2021 is expected to increase by 1177%-1525% year-on-year
2022-01-21 17:32
Source: Securities Times e Company
Author: Lee Jae-san
Securities Times · e company
Lee Jae-san
2022-01-21 17:32
Securities Times e Company News, Lisheng Pharmaceutical (002393) disclosed its performance forecast on the evening of January 21. It is expected that the net profit in 2021 will be 110 million to 140 million yuan, a year-on-year increase of 1176.8%-1525.02%. In the same period of last year, the company made a profit of 8.6153 million yuan. Last year, the company terminated the 23-valent pneumococcal polysaccharide vaccine project and made a large impairment provision of 58.15 million yuan for related assets. Affected by this factor, the net profit base of the previous year was low.
Disclaimer: Securities Times strives for true and accurate information. The content mentioned in the article is for reference only and does not constitute substantive investment advice. Operational risks are based on this.
4098691
Lisheng Pharmaceutical: Net profit in 2021 is expected to increase by 1177%-1525% year-on-year
6885
e company
news
1445
Lee Jae-san
2022-01-21